Covid-19 (Temas de Saúde Pública)
Relatório CDC | Taxas de hospitalização por Covid-19 foram 10 vezes mais altas entre adolescentes não vacinados do que entre os vacinados.
7 Set, 2021 | 22:09hComentários:
More kids hospitalized with Covid-19 in states with lower vaccination rates, CDC report finds – CNN
Child COVID hospital cases up in low-vaccination states – CIDRAP
Comentário no Twitter
From late June to mid-August, there was a 10x increase in the rate of hospitalizations among children ages 0-4 with #COVID19 while the #DeltaVariant was widely circulating. It is critical for children to #maskup and get vaccinated if eligible. Learn more: https://t.co/aHC1vYdKVG. pic.twitter.com/uUeNPG6d5r
— CDC (@CDCgov) September 3, 2021
[Ainda não publicado] Dose de reforço da Sinovac reverte a queda da atividade dos anticorpos contra a variante Delta em estudo.
7 Set, 2021 | 22:05hSinovac booster shot reverses drop in antibody activities against Delta-study – Reuters
Comentário no Twitter
A booster dose of Sinovac Biotech's COVID-19 vaccine reversed a decline in antibody activities against the Delta variant, a study showed, easing some concerns about its longer-term immune response to the highly contagious strain of the virus. https://t.co/QdmMYVBrvl
— Reuters Health (@Reuters_Health) September 6, 2021
Opinião | Vídeo: imunidade é o único caminho para atravessar uma pandemia (com Dra. Monica Gandhi).
7 Set, 2021 | 22:04hImmunity Is The Only Way Through A Pandemic (w/Dr. Monica Gandhi) – ZDoggMD
Mais dados mostram o risco aumentado de hospitalização pela variante Delta do SARS-CoV-2.
6 Set, 2021 | 16:36hHospitalisation associated with SARS-CoV-2 delta variant in Denmark – The Lancet Infectious Diseases
Estudo relacionado: Cohort study: Patients with Covid-19 infected with the Delta variant are twice as likely to need hospital admission or emergency care attendance.
O ressurgimento de infecção por SARS-CoV-2 em um sistema de saúde com altas taxas de vacinação: a eficácia da vacina contra a infecção foi reduzida de 90% entre março e junho para 65% em julho.
6 Set, 2021 | 16:33hConteúdos relacionados:
Another study shows Pfizer mRNA vaccine immunity is reduced over time.
Comentário no Twitter (fio – clique para saber mais)
💥 NEW DATA💥
1/ "Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce" published today in @NEJM details ↓ in vaccine effectiveness against INFECTION among @UCSDHealth employees – from 95%+ in the spring to 65% in July
👉🏽 https://t.co/wMgjoLgJzS pic.twitter.com/lgOwlEqUQG
— Christopher A. Longhurst (@calonghurst) September 1, 2021
Amplo estudo de vigilância mostra que são raros os eventos adversos graves após vacinação contra COVID-19 com vacinas mRNA.
6 Set, 2021 | 16:31hSurveillance for Adverse Events After COVID-19 mRNA Vaccination – JAMA
Editorial: Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink – JAMA
Comentários:
mRNA COVID vaccines not tied to serious side effects – CIDRAP
Researchers find no serious health effects linked to mRNA COVID-19 vaccines – News Medical
Comentário no Twitter
Concerned about the safety of mRNA vaccines? This study of 6.2 million people who got 11.8 million doses is immensely reassuring. https://t.co/nUIqTacl0g pic.twitter.com/JBvenRVrRc
— David Juurlink (@DavidJuurlink) September 4, 2021
Ponto de vista | Fortalecimento da segurança em saúde global e reformulação das regulações internacionais de saúde: para tornar o mundo mais seguro contra futuras pandemias.
6 Set, 2021 | 16:29hInfográficos interativos mostram os efeitos da variante Delta: como o coronavírus é disseminado em uma população e como se pode combatê-lo.
6 Set, 2021 | 16:28hHow coronavirus spreads through a population and how we can beat it – The Guardian
[Preprint] O maior estudo sobre máscaras demonstrou a importância delas na luta contra a Covid-19.
3 Set, 2021 | 12:55hLargest study of masks yet details their importance in fighting Covid-19 – NBC News
Estudo original: The Impact of Community Masking on COVID-19: A Cluster-Randomized Trial in Bangladesh – Innovations for Poverty Action
Ver também: A Study In Bangladesh Tripled The Rate Of Mask-Wearing. Can It Help In The U.S.? – NPR
Comentários no Twitter (fio – clique para saber mais)
This is arguably the most important single piece of epidemiological research of the entire pandemic.
A MASSIVE randomized trial launched a pro-mask campaign in some Bangladeshi villages, but not others.
The result: masking villages got less COVID. https://t.co/8uKPXAvvnU
— Lyman Stone 石來民 🦬🦬🦬 (@lymanstoneky) September 1, 2021
(fio do autor – clique para saber mais)
Some misinterpretation of our #Bangladesh Mask RCT by those who don’t read research, which I’ll ignore, but also some parochial/racist reactions, which I must respond to https://t.co/FFeqz1zox5
— Ahmed Mushfiq Mobarak (@mushfiq_econ) September 2, 2021
Estudo mostra que a vacinação reduz à metade o risco de “long COVID”.
3 Set, 2021 | 12:53hComunicado de imprensa: Double vaccination halves risk of Long COVID – King’s College London
Comentários:
Largest study of its kind finds face masks reduce COVID-19 – University of California – Berkeley
Study: Vaccines slash long-haul COVID, hospital rates – CIDRAP
Vaccination reduces risk of long Covid, even when people are infected, U.K. study indicates – STAT
Being fully vaccinated reduces odds of long-term Covid-19 symptoms by half, UK study suggests – CNN
Coronavirus vaccines cut risk of long Covid, study finds – BBC
Conteúdo relacionado: M-A: More than 50 long-term effects of COVID-19.
Comentário no Twitter
NEW evidence on breakthrough infections indicates people who tested positive for #SARS-CoV-2 after 1 or 2 vaccine doses had significantly lower odds of severe disease, hospitalisation, or #LongCOVID than unvaccinated. https://t.co/MgHt7Ztqa0 @TheLancetInfDis pic.twitter.com/nt2b7jVrH9
— The Lancet (@TheLancet) September 1, 2021